Detalles de la búsqueda
1.
Current IST-free/relapse-free survival as a new endpoint after allogeneic hematopoietic stem cell transplantation.
Ann Hematol
; 99(5): 1149-1150, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32185463
2.
Impact on Outcome of Minimal Residual Disease after Hematopoietic Stem Cell Transplantation with Fludarabine, Amsacrine, and Cytosine Arabinoside-Busulfan Conditioning: A Retrospective Monocentric Study.
Transplant Cell Ther
; 29(1): 38.e1-38.e9, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36108977
3.
Lyon-University Hospital Experience with Gemtuzumab Ozogamicin Therapy in Acute Myeloid Leukemia: a 'Real-Life' Study.
Mediterr J Hematol Infect Dis
; 12(1): e2020020, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32395209
4.
[Improving diagnosis coding in the ProMise database: Guidelines of the Francophone society of bone marrow transplantation and cellular therapy (SFGM-TC)]. / Difficultés de codage des diagnostics dans la base de données ProMISe : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC).
Bull Cancer
; 103(11S): S213-S219, 2016 Nov.
Artículo
en Francés
| MEDLINE | ID: mdl-27842859
5.
[Information and consent forms for hematopoietic stem cell transplantation donors and recipients: Guidelines from the Franchophone society of bone marrow transplantation and cellular therapy (SFGM-TC)]. / Greffe de cellules-souches hématopoïétiques Information et consentement des donneurs et des receveurs : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC).
Bull Cancer
; 103(11S): S198-S200, 2016 Nov.
Artículo
en Francés
| MEDLINE | ID: mdl-27842861
Resultados
1 -
5
de 5
1
Próxima >
>>